Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-000681-22Phase 4Completed
Phase 4, randomised trial in coronary arteriosclerosis comparing Iso-osmolar contrast medium (Visipaque) with Low-osmolar contrast medium (Ultravist 300) (2 arms). Primary endpoint: Intra-coronary opacification. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-000681-22.